Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | PGK1 | P00558 | 1/20 | 0.32 |
| ▸ | PGK2 | P07205 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.31 |
| ▸ | MPI | P34949 | 1/20 | 0.30 |
| ▸ | PGD | P52209 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL2367709 | 0.98 | SMN1; SMN2 (0.37) | LMNAALDH1A1SMN1; SMN2KDM4EDUSP3 | |
| SCHEMBL44010 | 0.87 | — | — | |
| SCHEMBL27811224 | 0.87 | — | — | |
| SCHEMBL27967282 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL11497228 | 0.84 | — | — | |
| SCHEMBL27602312 | 0.84 | — | — | |
| SCHEMBL5964870 | 0.84 | — | — | |
| Phosphoric Acid SCHEMBL3926567 | 0.82 | USP2 (0.43) | LMNAALDH1A1SMN1; SMN2KDM4EDUSP3 | |
| Phosphoric Acid SCHEMBL27624463 | 0.82 | LMNA (0.40) | LMNAALDH1A1SMN1; SMN2KDM4EDUSP3 | |
| Sulfuric Acid SCHEMBL28093814 | 0.80 | LMNA (0.38) | LMNAALDH1A1SMN1; SMN2KDM4EDUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2368433-B1 | Biocide compositions comprising glycerol(ether)phosphates | COGNIS IP MAN GMBH (DE) | 2014-05-07 | — | — | EP | claimed |
| WO-2011116891-A1 | BIOCIDE COMPOSITIONS COMPRISING GLYCEROL(ETHER)PHOSPHATES | COGNIS IP MANAGEMENT GMBH (DE) | 2011-09-29 | — | — | WO | claimed |
| EP-2368433-A1 | Biocide compositions comprising glycerol(ether)phosphates | Cognis IP Management GmbH (DE) | 2011-09-28 | — | — | EP | claimed |
| US-8883686-B2 | Biocide compositions comprising glycerol(ether)phosphates | COGNIS IP MANAGEMENT GMBH (DE) | 2014-11-11 | — | — | US | disclosed |
| US-8883686-B2 | Biocide compositions comprising glycerol(ether)phosphates | COGNIS IP MANAGEMENT GMBH (DE) | 2014-11-11 | — | — | US | disclosed |
| US-8883686-B2 | Biocide compositions comprising glycerol(ether)phosphates | COGNIS IP MANAGEMENT GMBH (DE) | 2014-11-11 | — | — | US | disclosed |
| EP-2368433-B1 | Biocide compositions comprising glycerol(ether)phosphates | COGNIS IP MAN GMBH (DE) | 2014-05-07 | — | — | EP | disclosed |
| EP-2368433-B1 | Biocide compositions comprising glycerol(ether)phosphates | COGNIS IP MAN GMBH (DE) | 2014-05-07 | — | — | EP | disclosed |
| CN-102892294-A | Biocide compositions comprising glycerol(ether)phosphates | COGNIS IP MAN GMBH | 2013-01-23 | — | — | CN | disclosed |
| CN-102892294-A | Biocide compositions comprising glycerol(ether)phosphates | COGNIS IP MAN GMBH | 2013-01-23 | — | — | CN | disclosed |
| US-20130012387-A1 | Biocide Compositions Comprising Glycerol(Ether)Phosphates | COGNIS IP MANAGEMENT GMBH (DE) | 2013-01-10 | — | — | US | disclosed |
| US-20130012387-A1 | Biocide Compositions Comprising Glycerol(Ether)Phosphates | COGNIS IP MANAGEMENT GMBH (DE) | 2013-01-10 | — | — | US | disclosed |
| WO-2011116891-A1 | BIOCIDE COMPOSITIONS COMPRISING GLYCEROL(ETHER)PHOSPHATES | COGNIS IP MANAGEMENT GMBH (DE) | 2011-09-29 | — | — | WO | disclosed |
| WO-2011116891-A1 | BIOCIDE COMPOSITIONS COMPRISING GLYCEROL(ETHER)PHOSPHATES | COGNIS IP MANAGEMENT GMBH (DE) | 2011-09-29 | — | — | WO | disclosed |
| EP-2368433-A1 | Biocide compositions comprising glycerol(ether)phosphates | Cognis IP Management GmbH (DE) | 2011-09-28 | — | — | EP | disclosed |
| EP-2368433-A1 | Biocide compositions comprising glycerol(ether)phosphates | Cognis IP Management GmbH (DE) | 2011-09-28 | — | — | EP | disclosed |
| EP-2368433-A1 | Biocide compositions comprising glycerol(ether)phosphates | Cognis IP Management GmbH (DE) | 2011-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130012387-A1 | Biocide Compositions Comprising Glycerol(Ether)Phosphates | MGLL, PHOSPHO1, GK | LMNA 3450/4885ALDH1A1 3771/4885SMN1; SMN2 4474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.